Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal Bleeding

Nonsteroidal antiinflammatory drugs, including low-dose aspirin, induce gastrointestinal complications. 1 – 3 Although new and potentially safer nonsteroidal antiinflammatory drugs (such as cyclooxygenase-2 inhibitors) are now in use, 4 it is uncertain whether these new drugs will reduce the number...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 343; no. 12; pp. 834 - 839
Main Authors Lanas, Angel, Bajador, Eduardo, Serrano, Pedro, Fuentes, Javier, Carreño, Sofía, Guardia, Jesusa, Sanz, Mercedes, Montoro, Miguel, Sáinz, Ricardo
Format Journal Article
LanguageEnglish
Published Boston, MA Massachusetts Medical Society 21.09.2000
Subjects
Online AccessGet full text
ISSN0028-4793
1533-4406
DOI10.1056/NEJM200009213431202

Cover

Abstract Nonsteroidal antiinflammatory drugs, including low-dose aspirin, induce gastrointestinal complications. 1 – 3 Although new and potentially safer nonsteroidal antiinflammatory drugs (such as cyclooxygenase-2 inhibitors) are now in use, 4 it is uncertain whether these new drugs will reduce the number of patients hospitalized with gastrointestinal bleeding. Over-the-counter nonsteroidal antiinflammatory drugs, especially aspirin, are the drugs most frequently associated with bleeding, 5 and the number of people taking low-dose aspirin is increasing. 3 Nonsteroidal antiinflammatory drugs that release nitric oxide are under investigation. 6 , 7 Nitric oxide increases blood flow in the gastric mucosa and inhibits the adherence of leukocytes to the endothelium within the gastrointestinal microcirculation. . . .
AbstractList BACKGROUND The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer.UNLABELLEDBACKGROUND The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer.We performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area.METHODSWe performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area.In the week before admission, 520 (46.3 percent) of the patients with bleeding had taken a nonsteroidal antiinflammatory drug other than low-dose aspirin, 120 (10.7 percent) had taken low-dose aspirin (< or = 300 mg per day), 60 (5.3 percent) a nitrovasodilator, and 135 (12.0 percent) an antisecretory agent such as a histamine H2-receptor antagonist or a proton-pump inhibitor. In multivariate models that adjusted for age, sex, and clinical risk factors, the use of a nonsteroidal antiinflammatory drug other than low-dose aspirin was independently associated with an increased risk of bleeding from a peptic ulcer (odds ratio, 7.4; 95 percent confidence interval, 4.5 to 12.0), as was the use of low-dose aspirin alone (odds ratio, 2.4; 95 percent confidence interval, 1.8 to 3.3). The use of a nitrovasodilator was associated with a decreased risk of bleeding (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.9), as was antisecretory therapy (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.8). In patients taking any type of nonsteroidai antiinflammatory drug, the use of a nitrovasodilator or antisecretory therapy was independently associated with a decreased risk of bleeding.RESULTSIn the week before admission, 520 (46.3 percent) of the patients with bleeding had taken a nonsteroidal antiinflammatory drug other than low-dose aspirin, 120 (10.7 percent) had taken low-dose aspirin (< or = 300 mg per day), 60 (5.3 percent) a nitrovasodilator, and 135 (12.0 percent) an antisecretory agent such as a histamine H2-receptor antagonist or a proton-pump inhibitor. In multivariate models that adjusted for age, sex, and clinical risk factors, the use of a nonsteroidal antiinflammatory drug other than low-dose aspirin was independently associated with an increased risk of bleeding from a peptic ulcer (odds ratio, 7.4; 95 percent confidence interval, 4.5 to 12.0), as was the use of low-dose aspirin alone (odds ratio, 2.4; 95 percent confidence interval, 1.8 to 3.3). The use of a nitrovasodilator was associated with a decreased risk of bleeding (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.9), as was antisecretory therapy (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.8). In patients taking any type of nonsteroidai antiinflammatory drug, the use of a nitrovasodilator or antisecretory therapy was independently associated with a decreased risk of bleeding.The use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding.CONCLUSIONSThe use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding.
Background The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer. Methods We performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area. Results In the week before admission, 520 (46.3 percent) of the patients with bleeding had taken a nonsteroidal antiinflammatory drug other than low-dose aspirin, 120 (10.7 percent) had taken low-dose aspirin (≤300 mg per day), 60 (5.3 percent) a nitrovasodilator, and 135 (12.0 percent) an antisecretory agent such as a histamine H2 -receptor antagonist or a proton-pump inhibitor. In multivariate models that adjusted for age, sex, and clinical risk factors, the use of a nonsteroidal antiinflammatory drug other than low-dose aspirin was independently associated with an increased risk of bleeding from a peptic ulcer (odds ratio, 7.4; 95 percent confidence interval, 4.5 to 12.0), as was the use of low-dose aspirin alone (odds ratio, 2.4; 95 percent confidence interval, 1.8 to 3.3). The use of a nitrovasodilator was associated with a decreased risk of bleeding (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.9), as was antisecretory therapy (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.8). In patients taking any type of nonsteroidal antiinflammatory drug, the use of a nitrovasodilator or antisecretory therapy was independently associated with a decreased risk of bleeding. Conclusions The use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding.
Nonsteroidal antiinflammatory drugs, including low-dose aspirin, induce gastrointestinal complications. 1 – 3 Although new and potentially safer nonsteroidal antiinflammatory drugs (such as cyclooxygenase-2 inhibitors) are now in use, 4 it is uncertain whether these new drugs will reduce the number of patients hospitalized with gastrointestinal bleeding. Over-the-counter nonsteroidal antiinflammatory drugs, especially aspirin, are the drugs most frequently associated with bleeding, 5 and the number of people taking low-dose aspirin is increasing. 3 Nonsteroidal antiinflammatory drugs that release nitric oxide are under investigation. 6 , 7 Nitric oxide increases blood flow in the gastric mucosa and inhibits the adherence of leukocytes to the endothelium within the gastrointestinal microcirculation. . . .
BACKGROUND The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer. We performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area. In the week before admission, 520 (46.3 percent) of the patients with bleeding had taken a nonsteroidal antiinflammatory drug other than low-dose aspirin, 120 (10.7 percent) had taken low-dose aspirin (< or = 300 mg per day), 60 (5.3 percent) a nitrovasodilator, and 135 (12.0 percent) an antisecretory agent such as a histamine H2-receptor antagonist or a proton-pump inhibitor. In multivariate models that adjusted for age, sex, and clinical risk factors, the use of a nonsteroidal antiinflammatory drug other than low-dose aspirin was independently associated with an increased risk of bleeding from a peptic ulcer (odds ratio, 7.4; 95 percent confidence interval, 4.5 to 12.0), as was the use of low-dose aspirin alone (odds ratio, 2.4; 95 percent confidence interval, 1.8 to 3.3). The use of a nitrovasodilator was associated with a decreased risk of bleeding (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.9), as was antisecretory therapy (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.8). In patients taking any type of nonsteroidai antiinflammatory drug, the use of a nitrovasodilator or antisecretory therapy was independently associated with a decreased risk of bleeding. The use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding.
The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer. We performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area. The use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding.
Author Carreño, Sofía
Sáinz, Ricardo
Serrano, Pedro
Bajador, Eduardo
Sanz, Mercedes
Fuentes, Javier
Montoro, Miguel
Lanas, Angel
Guardia, Jesusa
Author_xml – sequence: 1
  givenname: Angel
  surname: Lanas
  fullname: Lanas, Angel
– sequence: 2
  givenname: Eduardo
  surname: Bajador
  fullname: Bajador, Eduardo
– sequence: 3
  givenname: Pedro
  surname: Serrano
  fullname: Serrano, Pedro
– sequence: 4
  givenname: Javier
  surname: Fuentes
  fullname: Fuentes, Javier
– sequence: 5
  givenname: Sofía
  surname: Carreño
  fullname: Carreño, Sofía
– sequence: 6
  givenname: Jesusa
  surname: Guardia
  fullname: Guardia, Jesusa
– sequence: 7
  givenname: Mercedes
  surname: Sanz
  fullname: Sanz, Mercedes
– sequence: 8
  givenname: Miguel
  surname: Montoro
  fullname: Montoro, Miguel
– sequence: 9
  givenname: Ricardo
  surname: Sáinz
  fullname: Sáinz, Ricardo
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1501669$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10995862$$D View this record in MEDLINE/PubMed
BookMark eNqF0k1rFDEYwPEgFbutfgJBgogXO5q3STbHta1VWbcg9jw8M8nUrDPJNMkqPfnVzbIrhSI1l7n8_k8SJkfowAdvEXpOyVtKavludf75CyNlaUa54JQR9gjNaM15JQSRB2hGCJtXQml-iI5SWm8tFfoJOqRE63ou2Qz9Xrkcw09IwbgBcojpBC_Dr-osJIsXaXLR-RN8mb_biFfBp2xjcAYGvPDZOd8PMI7b7Bafxc11icEbXDT-6tIPHHp8NU0lvYBUtnE-25SdL_n7wVrj_PVT9LiHIdln--8xuvpw_u30Y7W8vPh0ulhWnaxJrjojpBWtYbqtlWxb07aWinkPLSdgwQgCPWm1kpwbpiiojvcUJCuo08B7foxe7-ZOMdxsyima0aXODgN4GzapUYxxrRT5L6RKKq3mosCX9-A6bGK5W2q2s2pKNS3oxR5t2tGaZopuhHjb_P0BBbzaA0gdDH0E37l052pCpdSF6R3rYkgp2r7pXIbsgs8R3FDmNds30fzjTZSW32vvTvFQ9WZXjWNqvF2PD-o_gmLFfg
CODEN NEJMAG
CitedBy_id crossref_primary_10_1016_S0210_5705_01_70192_6
crossref_primary_10_1111_j_1365_2036_2011_04707_x
crossref_primary_10_1007_s11888_006_0011_1
crossref_primary_10_4137_CMT_S7253
crossref_primary_10_1016_j_hoc_2006_03_002
crossref_primary_10_1021_acs_joc_3c01911
crossref_primary_10_1186_1471_230X_13_136
crossref_primary_10_1016_S1590_8658_03_00048_3
crossref_primary_10_1093_eurheartj_ehp256
crossref_primary_10_3748_wjg_v12_i18_2923
crossref_primary_10_1016_S0895_4356_03_00255_5
crossref_primary_10_3109_00365521_2010_510567
crossref_primary_10_1007_s11938_006_0033_4
crossref_primary_10_1097_00132579_200211000_00004
crossref_primary_10_1161_CIRCULATIONAHA_113_004747
crossref_primary_10_1016_j_mehy_2012_11_025
crossref_primary_10_1185_030079907X162656
crossref_primary_10_1097_00132579_200105000_00003
crossref_primary_10_1016_j_dld_2004_05_011
crossref_primary_10_1016_j_ahj_2011_08_007
crossref_primary_10_1016_S0300_8932_02_76653_0
crossref_primary_10_1007_s00535_009_0068_0
crossref_primary_10_1007_s10620_005_1281_1
crossref_primary_10_1053_bega_2001_0192
crossref_primary_10_1136_pmj_78_915_4
crossref_primary_10_1007_s10620_008_0702_3
crossref_primary_10_1006_phrs_2001_0933
crossref_primary_10_1007_s00228_012_1386_3
crossref_primary_10_1111_j_1365_2036_2004_02246_x
crossref_primary_10_1136_ard_2004_023572
crossref_primary_10_1111_1751_2980_12000
crossref_primary_10_1038_nrgastro_2018_5
crossref_primary_10_3390_jcm9040928
crossref_primary_10_3748_wjg_v11_i37_5828
crossref_primary_10_1016_j_carrev_2008_11_001
crossref_primary_10_1211_jpp_57_12_0004
crossref_primary_10_1177_2050640613491254
crossref_primary_10_1111_j_1440_1746_2010_06229_x
crossref_primary_10_4253_wjge_v4_i7_323
crossref_primary_10_1111_j_1365_2036_2004_02078_x
crossref_primary_10_4292_wjgpt_v15_i3_92305
crossref_primary_10_1093_qjmed_hcg090
crossref_primary_10_1111_j_1651_2227_2002_tb01659_x
crossref_primary_10_1016_j_clinthera_2008_01_020
crossref_primary_10_2165_00002512_200724020_00004
crossref_primary_10_1016_j_gastrohep_2008_02_001
crossref_primary_10_1016_S1590_8658_03_00047_1
crossref_primary_10_1517_14740338_2010_501331
crossref_primary_10_1111_j_1365_2036_2004_02297_x
crossref_primary_10_1111_j_1572_0241_2002_07134_x
crossref_primary_10_1053_j_gastro_2016_09_006
crossref_primary_10_3389_jpps_2023_11136
crossref_primary_10_1056_NEJMoa042087
crossref_primary_10_1097_HCO_0b013e32832e2b44
crossref_primary_10_1097_00001574_200111000_00005
crossref_primary_10_1097_01_ebg_0000162248_43421_30
crossref_primary_10_1157_13098291
crossref_primary_10_1007_s00535_008_2206_5
crossref_primary_10_1080_07853890600925843
crossref_primary_10_1111_j_1365_2036_2005_02649_x
crossref_primary_10_1016_S1134_2072_04_76225_8
crossref_primary_10_1053_berh_2001_0196
crossref_primary_10_1053_j_gastro_2003_11_046
crossref_primary_10_1038_ncpgasthep0559
crossref_primary_10_3999_jscpt_42_369
crossref_primary_10_17116_terarkh2014861298_103
crossref_primary_10_1592_phco_28_6_788
crossref_primary_10_1124_jpet_103_063453
crossref_primary_10_1136_gutjnl_2019_318352
crossref_primary_10_1016_S0248_8663_00_00322_2
crossref_primary_10_1056_NEJMra052717
crossref_primary_10_1080_13880209_2017_1285326
crossref_primary_10_1053_j_gastro_2014_06_007
crossref_primary_10_1046_j_1365_2125_2003_01774_x
crossref_primary_10_1111_j_1365_2036_2004_02150_x
crossref_primary_10_1111_j_1572_0241_2007_01715_x
crossref_primary_10_1080_03007995_2017_1281110
crossref_primary_10_1111_j_1365_2036_2006_03077_x
crossref_primary_10_1111_j_1440_1746_2009_06212_x
crossref_primary_10_1002_ptr_1793
crossref_primary_10_1007_s00535_012_0717_6
crossref_primary_10_11641_pde_83_1_56
crossref_primary_10_1097_MD_0000000000001047
crossref_primary_10_1001_jamanetworkopen_2023_43219
crossref_primary_10_1007_BF03327372
crossref_primary_10_1016_j_dld_2004_06_010
crossref_primary_10_1111_j_0269_2813_2004_01834_x
crossref_primary_10_1097_00005344_200605001_00011
crossref_primary_10_1007_s00535_015_1038_3
crossref_primary_10_1016_j_clinbiochem_2007_01_015
crossref_primary_10_1080_03007995_2017_1338178
crossref_primary_10_1080_07853890_2021_2016940
crossref_primary_10_1016_S1134_2072_07_71845_5
crossref_primary_10_1038_nrmicro929
crossref_primary_10_1111_j_1365_2036_2006_02759_x
crossref_primary_10_1111_j_1365_2036_2006_03043_x
crossref_primary_10_1046_j_1523_1755_2003_00225_x
crossref_primary_10_2165_11593880_000000000_00000
crossref_primary_10_1016_S1155_1968_03_00070_1
crossref_primary_10_1111_j_1365_2036_2008_03836_x
crossref_primary_10_5649_jjphcs_32_548
crossref_primary_10_1053_gast_2003_50096
crossref_primary_10_1016_S1590_8658_01_80156_0
crossref_primary_10_1097_00132579_200302000_00003
crossref_primary_10_1097_MCG_0b013e3181a9f43b
crossref_primary_10_1161_CIRCULATIONAHA_108_191087
crossref_primary_10_1016_j_clinthera_2006_09_015
crossref_primary_10_1080_10543406_2013_736813
crossref_primary_10_1111_j_1572_0241_2008_02216_x
crossref_primary_10_1016_j_clinthera_2013_02_008
crossref_primary_10_3748_wjg_v11_i25_3811
crossref_primary_10_1016_j_diabet_2017_11_002
crossref_primary_10_1016_S0210_5705_01_70130_6
crossref_primary_10_1016_S0399_8320_04_95285_2
crossref_primary_10_1007_s10049_016_0184_3
crossref_primary_10_1016_j_giec_2011_07_004
crossref_primary_10_1016_j_jacc_2008_08_002
crossref_primary_10_1157_13084890
crossref_primary_10_1038_s41397_020_00185_6
crossref_primary_10_1039_C7GC02682J
crossref_primary_10_1046_j_1365_2036_2002_01355_x
crossref_primary_10_1124_jpet_105_089896
crossref_primary_10_1038_sj_bjp_0707396
crossref_primary_10_1016_j_ddstr_2006_09_004
crossref_primary_10_1111_j_1440_1746_2012_07071_x
crossref_primary_10_1016_j_amjmed_2004_07_010
crossref_primary_10_1016_j_cgh_2011_05_020
crossref_primary_10_1002_1615_1003_200203_31_2_206__AID_PAUZ206_3_0_CO_2
crossref_primary_10_1097_MCG_0b013e31811edd13
crossref_primary_10_1002_pds_988
crossref_primary_10_1080_00365520510024197
crossref_primary_10_1007_s10620_005_9052_6
crossref_primary_10_1097_FPC_0000000000000186
crossref_primary_10_1111_j_1365_2036_2005_02715_x
crossref_primary_10_1007_s00228_005_0026_6
crossref_primary_10_1097_00045391_200401000_00007
crossref_primary_10_1111_ijcp_12634
crossref_primary_10_2478_jce_2018_0006
crossref_primary_10_1016_j_gastrohep_2009_09_009
crossref_primary_10_1016_j_gtc_2009_03_005
crossref_primary_10_1016_S0210_5705_03_70400_2
crossref_primary_10_1016_S1134_2072_07_71541_4
crossref_primary_10_1053_j_gastro_2011_03_049
crossref_primary_10_31744_einstein_journal_2024AO0746
crossref_primary_10_1007_s10753_009_9176_5
crossref_primary_10_1097_00042737_200302000_00011
crossref_primary_10_5009_gnl_2008_2_2_99
crossref_primary_10_1007_s10620_014_3415_9
crossref_primary_10_1016_j_cgh_2009_03_015
crossref_primary_10_1007_s10620_005_2906_0
crossref_primary_10_1001_jama_2024_19094
crossref_primary_10_1016_j_annemergmed_2005_12_012
crossref_primary_10_1097_FPC_0b013e328346d2bb
crossref_primary_10_1007_s00535_008_2290_6
crossref_primary_10_1016_j_rhum_2009_04_008
crossref_primary_10_1016_j_tice_2024_102685
crossref_primary_10_1111_j_1365_2710_2004_00551_x
crossref_primary_10_1016_j_cgh_2012_03_027
crossref_primary_10_1007_s12328_010_0198_1
crossref_primary_10_1046_j_1365_2036_2002_01230_x
crossref_primary_10_1186_1741_7015_4_22
crossref_primary_10_1177_147323000903700637
crossref_primary_10_1016_j_bpg_2009_10_006
crossref_primary_10_1053_bega_2001_0230
crossref_primary_10_1053_j_gastro_2017_10_049
crossref_primary_10_1186_1471_2296_13_23
crossref_primary_10_1186_1471_230X_9_36
crossref_primary_10_7793_jcoron_18_011
crossref_primary_10_2165_00128415_200008210_00009
crossref_primary_10_1211_0022357056028
crossref_primary_10_1056_NEJMoa012877
crossref_primary_10_1111_j_0953_0673_2004_01840_x
crossref_primary_10_1152_ajpgi_00469_2009
crossref_primary_10_1016_j_giec_2006_01_001
crossref_primary_10_17517_ksutfd_671049
crossref_primary_10_1681_ASN_2011070658
crossref_primary_10_3390_medicina54020030
crossref_primary_10_1016_j_jacc_2004_03_079
crossref_primary_10_1016_S0399_8320_04_95278_5
crossref_primary_10_1253_circj_CJ_14_0582
crossref_primary_10_1053_gast_2003_50121
crossref_primary_10_2165_00003495_200666001_00005
crossref_primary_10_1016_S0090_6980_02_00003_5
crossref_primary_10_1053_j_gastro_2009_09_063
crossref_primary_10_1016_j_cgh_2009_03_032
crossref_primary_10_1046_j_0306_5251_2001_01476_x
crossref_primary_10_1007_s11748_011_0886_x
crossref_primary_10_1038_ncpgasthep0393
crossref_primary_10_2165_00002018_200427060_00005
crossref_primary_10_1053_j_gastro_2004_05_001
crossref_primary_10_1002_art_20422
crossref_primary_10_1111_j_1365_2036_2004_02341_x
crossref_primary_10_1016_j_bpg_2012_01_011
crossref_primary_10_1007_s00535_018_1483_x
crossref_primary_10_1016_j_bpg_2012_01_015
crossref_primary_10_1038_s41598_021_99402_w
crossref_primary_10_1016_S0399_8320_04_95283_9
crossref_primary_10_1016_j_bpg_2012_01_013
crossref_primary_10_4103_0366_6999_173480
crossref_primary_10_1007_s11926_001_0069_3
crossref_primary_10_1016_j_bpg_2012_01_016
crossref_primary_10_1056_NEJM200103293441304
crossref_primary_10_1111_j_1365_2036_2008_03713_x
crossref_primary_10_1007_s00535_006_1886_y
crossref_primary_10_1097_00042737_200106000_00001
crossref_primary_10_1016_j_freeradbiomed_2006_07_020
crossref_primary_10_1053_j_gastro_2005_08_051
crossref_primary_10_1002_jemt_1099
crossref_primary_10_1046_j_1472_8206_2003_00135_x
crossref_primary_10_17795_zjrms_1056
crossref_primary_10_3810_pgm_2005_06_1657
crossref_primary_10_1016_j_intimp_2010_11_002
crossref_primary_10_1111_jgh_12805
crossref_primary_10_1186_s40001_023_01413_y
crossref_primary_10_1586_ecp_11_36
crossref_primary_10_1002_pds_546
crossref_primary_10_1016_j_jtcvs_2017_02_012
crossref_primary_10_1186_1756_0500_6_455
crossref_primary_10_1111_apt_12240
crossref_primary_10_1517_13543784_14_11_1347
crossref_primary_10_1016_S0210_5705_11_70005_X
crossref_primary_10_1016_S0300_8932_01_76517_7
crossref_primary_10_1016_j_bpg_2012_01_005
crossref_primary_10_1163_156856905774482797
crossref_primary_10_1007_s40256_014_0088_x
crossref_primary_10_1371_journal_pone_0160046
crossref_primary_10_1046_j_1365_2036_2003_01762_x
crossref_primary_10_1016_S1169_8330_04_80023_1
crossref_primary_10_1016_j_cgh_2006_04_019
crossref_primary_10_1186_1865_1380_4_34
crossref_primary_10_1590_s0004_2803_202100000_36
crossref_primary_10_1111_apt_13642
crossref_primary_10_1111_j_1527_3466_2006_00148_x
crossref_primary_10_1517_13543776_15_1_9
crossref_primary_10_1159_000076542
crossref_primary_10_2165_00002018_200124110_00002
crossref_primary_10_1007_s00228_006_0171_6
crossref_primary_10_2146_ajhp070244
crossref_primary_10_1016_S0025_7753_08_72279_6
crossref_primary_10_1152_ajpgi_00435_2006
crossref_primary_10_1007_s11606_012_2208_0
crossref_primary_10_1016_j_ejphar_2010_09_012
crossref_primary_10_1056_NEJMoa1007964
crossref_primary_10_1007_s11739_019_02191_4
crossref_primary_10_3109_00365521_2015_1057861
crossref_primary_10_1161_HYPERTENSIONAHA_107_092866
crossref_primary_10_1163_156856003322699582
crossref_primary_10_1021_jm050211k
crossref_primary_10_1097_HCO_0b013e3283652dad
crossref_primary_10_1016_S0140_6736_10_60673_3
crossref_primary_10_3810_pgm_2014_01_2721
crossref_primary_10_1007_s10620_007_0178_6
crossref_primary_10_1097_MCG_0b013e318203677f
crossref_primary_10_1016_S0025_7753_02_72344_0
crossref_primary_10_1007_s10654_014_9971_7
crossref_primary_10_1186_s12882_020_01757_1
crossref_primary_10_1007_s10620_006_9266_2
crossref_primary_10_1097_HPC_0b013e318159921e
crossref_primary_10_1002_pds_1592
crossref_primary_10_1097_00063110_200312000_00010
crossref_primary_10_1007_s11938_002_0062_6
crossref_primary_10_1016_S0399_8320_04_95276_1
crossref_primary_10_2165_00003495_200969010_00004
crossref_primary_10_1074_jbc_M609426200
crossref_primary_10_1002_jemt_1100
crossref_primary_10_1111_j_1572_0241_2006_01062_x
crossref_primary_10_1161_CIRCULATIONAHA_116_023164
crossref_primary_10_1038_nrgastro_2011_97
crossref_primary_10_1097_01_shk_0000192122_91166_a8
crossref_primary_10_1111_j_1532_5415_2007_01346_x
crossref_primary_10_1111_apt_14079
crossref_primary_10_2165_11585320_000000000_00000
crossref_primary_10_1002_art_27412
crossref_primary_10_1002_pds_1387
crossref_primary_10_1016_S1590_8658_03_00049_5
crossref_primary_10_3109_00365521_2012_758771
crossref_primary_10_1080_17512433_2017_1324782
crossref_primary_10_3390_molecules27196587
crossref_primary_10_1053_j_ajkd_2008_01_035
crossref_primary_10_2169_internalmedicine_48_2031
crossref_primary_10_3390_antiox8110512
crossref_primary_10_1016_S0399_8320_04_95277_3
crossref_primary_10_1111_j_1440_1746_2006_04811_x
crossref_primary_10_1371_journal_pone_0015721
crossref_primary_10_1111_j_1572_0241_2008_02200_x
crossref_primary_10_1134_S0012500809040065
crossref_primary_10_1038_nrd794
crossref_primary_10_1097_00002281_200205000_00005
crossref_primary_10_1517_14740338_2010_507629
crossref_primary_10_1080_09537100500237004
crossref_primary_10_1007_s10654_004_6856_1
crossref_primary_10_1016_j_ejim_2017_05_017
crossref_primary_10_1016_j_jbspin_2009_11_008
Cites_doi 10.1016/0016-5085(92)90018-T
10.7326/0003-4819-114-4-307
10.1016/0016-5085(94)90074-4
10.1152/ajpcell.1990.259.3.C462
10.1016/S0140-6736(94)91843-0
10.1016/0016-5085(95)90341-0
10.3109/00365529509107758
10.1016/0014-2999(95)00399-6
10.1097/00001648-199905000-00006
10.1177/030006059802600302
10.1053/gast.1997.v112.pm9041264
10.1016/S0016-5085(99)70120-4
10.7326/0003-4819-114-4-257
10.1172/JCI118704
10.1136/gut.39.5.654
10.1136/bmj.310.6983.827
10.1001/archinte.156.14.1530
10.1053/gast.1997.v112.pm9041228
10.1073/pnas.90.24.11693
10.1111/j.1476-5381.1993.tb13442.x
10.1016/S0049-3848(98)00134-0
10.1016/S0140-6736(96)01254-8
ContentType Journal Article
Copyright Copyright © 2000 Massachusetts Medical Society. All rights reserved.
2000 INIST-CNRS
Copyright_xml – notice: Copyright © 2000 Massachusetts Medical Society. All rights reserved.
– notice: 2000 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7T2
7U1
C1K
7X8
DOI 10.1056/NEJM200009213431202
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Hospital Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest British Nursing Database
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
New England Journal of Medicine
ProQuest Biological Science Collection
Consumer Health Database
Healthcare Administration Database
Medical Database
Psychology Database
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
Health and Safety Science Abstracts (Full archive)
Risk Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
Risk Abstracts
Health & Safety Science Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Psychology

MEDLINE
Risk Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 839
ExternalDocumentID 60746546
10995862
1501669
10_1056_NEJM200009213431202
NJ200009213431202
Genre Original Article
Research Support, Non-U.S. Gov't
Journal Article
General Information
GroupedDBID -
08R
0R
0WA
123
186
1AW
1KJ
1VV
29N
2KS
2WC
34G
39C
3O-
3V.
4
4.4
53G
55
5D0
5RE
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
8RP
AACLI
AAEJM
AAIKC
AALRV
AAPBV
AAQQT
AARDX
AASXA
AAUTI
AAWTL
ABACO
ABEFU
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQES
ABQIJ
ABUFD
ABUWG
ABWJO
ACDCL
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACPVT
ACRZS
ACTDY
ACVYA
ADBBV
ADCBC
AENEX
AETEA
AFDAS
AFFDN
AFFNX
AFKRA
AFMIJ
AGNAY
AHMBA
AHVBC
AIKQT
AJJEV
AJUXI
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCR
BCU
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
EJD
ET
EX3
F20
F5P
FD8
FM.
FYUFA
G8K
GJ
GNUQQ
GUQSH
HCIFZ
HZ
IH2
J5H
K-O
K78
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
MVM
N9A
NEJ
NHB
O0-
O9-
OHM
OHT
OK1
OMK
OVD
P-O
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QZG
RHI
RWL
RXW
S6N
SJFOW
SJN
SKT
TAE
TAF
TN5
TWZ
U1N
UCV
UHB
UKR
VQA
W2G
WH7
WOQ
WOW
X
X7M
XFK
XJT
XYN
XZL
YCJ
YHZ
YNT
YQJ
YZZ
ZA5
ZGI
ZHY
ZKB
ZKG
ZXP
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
1CY
36B
6TJ
AAMNW
AAYOK
AAYXX
ABBLC
ABCQX
ABDPE
ABDQB
ABJNI
ACKOT
ACPFK
ADRHT
ADUKH
ADXHL
AERZD
AFOSN
AGFXO
AGHSJ
ALIPV
BYPQX
CCPQU
CITATION
HF~
HMCUK
HZ~
N4W
NAPCQ
PHGZM
PHGZT
PSYQQ
TEORI
TUQ
UKHRP
WHG
XOL
YFH
YR2
YR5
YYP
ZCA
ZR0
ZVN
~KM
41~
8WZ
9M8
A6W
AAQOH
AFHKK
D0S
FA8
H13
IQODW
LPU
MQT
PJZUB
PPXIY
PQGLB
QJJ
S10
UBX
UMD
UQL
YQI
YRY
YYQ
CGR
CUY
CVF
ECM
EIF
NPM
R.3
UIG
VXZ
YIF
YIN
Z5M
7XB
BEC
K0Y
PKEHL
Q9U
7T2
7U1
C1K
PUEGO
7X8
ID FETCH-LOGICAL-c650t-cd46e4bd29b576bbdbbe148fab30aead40af0b97633d271a7c3f1a62e14c9a3f3
IEDL.DBID 7X7
ISSN 0028-4793
IngestDate Thu Sep 04 19:15:01 EDT 2025
Fri Sep 05 08:02:42 EDT 2025
Sat Aug 23 13:36:41 EDT 2025
Wed Feb 19 01:20:28 EST 2025
Mon Jul 21 09:14:34 EDT 2025
Tue Jul 01 03:10:02 EDT 2025
Thu Apr 24 23:08:51 EDT 2025
Wed Nov 11 00:32:59 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Human
Vasodilator agent
Toxicity
Cardiovascular disease
Acetylsalicylic acid
Case control study
Risk analysis
Gastrointestinal
Hemorrhage
Vascular disease
Non steroidal antiinflammatory agent
Prospective
Chemotherapy
Nitric oxide
Nitroglycerin
Organic nitrate
Digestive diseases
Intestinal disease
Salicylates
Gastric disease
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c650t-cd46e4bd29b576bbdbbe148fab30aead40af0b97633d271a7c3f1a62e14c9a3f3
Notes SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://www.nejm.org/doi/pdf/10.1056/NEJM200009213431202?articleTools=true
PMID 10995862
PQID 223951191
PQPubID 40644
PageCount 6
ParticipantIDs proquest_miscellaneous_72239770
proquest_miscellaneous_17679784
proquest_journals_223951191
pubmed_primary_10995862
pascalfrancis_primary_1501669
crossref_citationtrail_10_1056_NEJM200009213431202
crossref_primary_10_1056_NEJM200009213431202
mms_nejm_10_1056_NEJM200009213431202
ProviderPackageCode DCD
7FN
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2000-09-21
PublicationDateYYYYMMDD 2000-09-21
PublicationDate_xml – month: 09
  year: 2000
  text: 2000-09-21
  day: 21
PublicationDecade 2000
PublicationPlace Boston, MA
PublicationPlace_xml – name: Boston, MA
– name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 2000
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References Weil J (r003) 1995; 310
Wallace JL (r006) 1994; 107
r020
r021
r011
r022
r012
r023
Lanas A (r005) 1992; 103
Lanas A (r015) 1998; 26
r007
Lopez-Belmonte J (r010) 1993; 108
r019
Wallace JL (r008) 1990; 259
r009
r002
r013
r014
r004
r016
Donnelly MT (r017) 1998; 114
Griffin MR (r024) 1991; 114
Petroski D (r018) 1993; 15
Soll AH (r001) 1991; 114
References_xml – volume: 103
  start-page: 862
  year: 1992
  ident: r005
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(92)90018-T
– volume: 114
  start-page: 307
  year: 1991
  ident: r001
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-114-4-307
– volume: 107
  start-page: 173
  year: 1994
  ident: r006
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(94)90074-4
– volume: 259
  start-page: G462
  year: 1990
  ident: r008
  publication-title: Am J Physiol
  doi: 10.1152/ajpcell.1990.259.3.C462
– ident: r002
  doi: 10.1016/S0140-6736(94)91843-0
– ident: r012
  doi: 10.1016/0016-5085(95)90341-0
– volume: 15
  start-page: 314
  year: 1993
  ident: r018
  publication-title: Clin Ther
– ident: r020
  doi: 10.3109/00365529509107758
– ident: r011
  doi: 10.1016/0014-2999(95)00399-6
– ident: r022
  doi: 10.1097/00001648-199905000-00006
– volume: 26
  start-page: 120
  year: 1998
  ident: r015
  publication-title: J Int Med Res
  doi: 10.1177/030006059802600302
– ident: r007
  doi: 10.1053/gast.1997.v112.pm9041264
– ident: r009
  doi: 10.1016/S0016-5085(99)70120-4
– volume: 114
  start-page: 257
  year: 1991
  ident: r024
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-114-4-257
– ident: r014
  doi: 10.1172/JCI118704
– ident: r013
  doi: 10.1136/gut.39.5.654
– volume: 310
  start-page: 827
  year: 1995
  ident: r003
  publication-title: BMJ
  doi: 10.1136/bmj.310.6983.827
– volume: 114
  start-page: A107
  year: 1998
  ident: r017
  publication-title: Gastroenterology
– ident: r021
  doi: 10.1001/archinte.156.14.1530
– ident: r023
  doi: 10.1053/gast.1997.v112.pm9041228
– ident: r004
  doi: 10.1073/pnas.90.24.11693
– volume: 108
  start-page: 73
  year: 1993
  ident: r010
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1993.tb13442.x
– ident: r016
  doi: 10.1016/S0049-3848(98)00134-0
– ident: r019
  doi: 10.1016/S0140-6736(96)01254-8
SSID ssj0000149
Score 2.2135956
Snippet Nonsteroidal antiinflammatory drugs, including low-dose aspirin, induce gastrointestinal complications. 1 – 3 Although new and potentially safer nonsteroidal...
BACKGROUND The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding...
Background The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding...
The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is...
SourceID proquest
pubmed
pascalfrancis
crossref
mms
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 834
SubjectTerms Aged
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
antiinflammatory agents
Aspirin
Aspirin - adverse effects
Biological and medical sciences
bleeding
Case-Control Studies
Digestive system
Drug Interactions
Drug Therapy, Combination
Drug toxicity and drugs side effects treatment
Drugs
Esophagitis - chemically induced
Esophagitis - prevention & control
Female
Gastrointestinal Hemorrhage - chemically induced
Gastrointestinal Hemorrhage - prevention & control
gastrointestinal tract
Hemorrhage
Humans
Logistic Models
Male
Medical sciences
Middle Aged
Nitrates - metabolism
Nitrates - therapeutic use
Nitric Oxide - metabolism
Odds Ratio
Peptic Ulcer Hemorrhage - chemically induced
Peptic Ulcer Hemorrhage - prevention & control
Pharmacology. Drug treatments
Risk Factors
Toxicity: digestive system
Ulcers
Vasodilator Agents - therapeutic use
Title Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal Bleeding
URI http://dx.doi.org/10.1056/NEJM200009213431202
https://www.ncbi.nlm.nih.gov/pubmed/10995862
https://www.proquest.com/docview/223951191
https://www.proquest.com/docview/17679784
https://www.proquest.com/docview/72239770
Volume 343
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9swDBbWFhh2Gda9mnXtdOgxQv2Qpeg0bEWLosCCYViB3AxRkgsPiZ3FCXbcXx8ly1kLtLn4YFOyLFLiR5EmCTmT0qnMGWCQSs04VwkD4So2SQXeKQxwHaItpuL6lt_MilmMzeliWOWwJ4aN2rbGn5GfoxpT3ueVfl7-Zr5olHeuxgoae-QgZC5DcZYzeS97VES_8QBpSDpUiHNfaD4L-MhnNMvTLB6rDIppb7HofJik7nCmqr7ExdMYNOiiq1fkZQSR9EvP9UPyzDWvyfNv0U3-hvyd1uuVDzJtbT33VnU3pvP2D7Nt56j2vvW6GdPw7xVtPEB0q7a22CNOc40ih1KyCN53alebO2ysG0uRmvpAdNpWdLNcYtM73eFrfMIJ3Cf8gGDe68K35Pbq8ufFNYuVFphBhLZmxnLhONhMAdofABbAoZ1UacgTjbLGE10lgMglz20mUy1NXqVaZEhklM6r_B3Zx-G6I0IFaOR9AXKiJhy00QigEi0gqcBwU6gRyYZpLk1MQ-6rYczL4A4vRPkIb0ZkvG207LNw7CY_Q_6Vjfu12E128oDB_7suEAgLHOrxwPAyruyu3MrhiHzaPsUl6f0sunHtpitTKSQa5_xpCul7kTIZkfe9HN37KqUKtDI_7Hz3MXnRpwRQLEs_kv31auNOEByt4TQsAbxOLtJTcvD1cvr9xz_yug0J
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61Wwm4IJ5lKaU-lNtaTRzHXh8Q4tFqS9sVQq3UW7AdpwraTZbNripO_CL-I-M8liLRvfWajB3HM5757BnPAOxL6RRz1lATSk05VwE1wmV0GAp8ElvDdR1tMRajC_75Mr7cgN_dXRgfVtnpxFpRp6X1Z-QHaMaU93mF72Y_qC8a5Z2rXQWNRipO3M9r3LFVb48_IXvfMHZ0eP5xRNuiAtQiGFlQm3LhuEmZMgi1jUmNcbglyLSJAo3TygOdBQaNdBSlTIZa2igLtWBIZJWOsgj73YQt7i-09mDrw-H4y9cb-apavN0eWXVpjmJx4EvbsxqR-RxqUcjag5zOFG5Op5UPzNQV8iZrimrcjnpr63f0CB62sJW8b-TsMWy44gncO2sd80_h1zhfzH1Ya5nmE7-PrwZkUl7TtKwc0d6bnxcDUt_2IoWHpG5e5in2iIzNUchRLqe1v5-k8-UVNtZFSpCa-NB3UmZkOZth0ytd4Wd8igvUTH5AZtJY32dwcSdseA49HK57AUQYjdIWGzlUQ2601QjZAi1MkBnLbaz6wLppTmyb-NzX35gktQM-Fsl_eNOHwarRrMn7sZ58H_mXFO77dD3Z7j8M_tt1jNBb4FB3OoYnrS6pkpXk92Fv9RaVgPfs6MKVyyoJpZBKDvntFNL3ImXQh-1Gjm78lVIx7mtfrv32HtwfnZ-dJqfH45MdeNAkJFCUha-gt5gv3S5Cs4V53S4IAt_ueg3-ASEhSx0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61Raq4IN4NpXQP5ZZV7PV6N3tACFGilkLEgUq5mX25CkrsECeqOPG7-HfM-hGKRHPr1Z5drz2vb3fGMwAnUnrFvDXUxFJTzlVEjfA5HcYCr6TWcF1nW4zF2SX_OEknO_C7-xcmpFV2NrE21K604Yx8gG5MhZhXPMjbrIgvp6O3ix80NJAKgdaum0YjIRf-5zXu3qo356fI6teMjT58fX9G2wYD1CIwWVHruPDcOKYMwm5jnDEetwe5Nkmk8RPzSOeRQYedJI7JWEub5LEWDIms0kme4Ly7cE8mCKpQleRE3qhc1SLv9vCqK3iUikFocs9qbBaqqSUxa490Oqe4O59XIUVTV8ilvGmvcTv-rf3g6CE8aAEseddI3CPY8cVj2P_chuifwK_xdLUMCa6lm87Cjr7qk1l5TV1ZeaJDXH9a9En93xcpAjj1y3LqcEZk8RTFHSV0Xkf-iVuur3CwLhxBahKS4EmZk_VigUOvdIWPCcUu0EaFBZlZ44efwuWdMOEZ7OFy_QEQYTTKXWrkUA250VYjeIu0MFFuLLep6gHrPnNm2xLooRPHLKtD8anI_sObHvQ3gxZNBZDt5CfIv6zw3-fbyY7-YfDfqVME4QKXetgxPGutSpVtdKAHx5u7aA5CjEcXvlxXWSyFVHLIb6eQYRYpox48b-ToxlspleIO98XWZx_DPmpe9ul8fHEI95vKBIqy-CXsrZZrf4QYbWVe1dpA4Ntdq98fy-hN5A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nitrovasodilators%2C+low-dose+aspirin%2C+other+nonsteroidal+antiinflammatory+drugs%2C+and+the+risk+of+upper+gastrointestinal+bleeding&rft.jtitle=The+New+England+journal+of+medicine&rft.au=LANAS%2C+Angel&rft.au=BAJADOR%2C+Eduardo&rft.au=SERRANO%2C+Pedro&rft.au=FUENTES%2C+Javier&rft.date=2000-09-21&rft.pub=Massachusetts+Medical+Society&rft.issn=0028-4793&rft.volume=343&rft.issue=12&rft.spage=834&rft.epage=839&rft_id=info:doi/10.1056%2FNEJM200009213431202&rft.externalDBID=n%2Fa&rft.externalDocID=1501669
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon